OBJECTIVES: To identify the real world standard of care, treatment patterns, medical history, resource use and costs of patients with choroidal neovascularization (CNV) secondary to pathologic myopia (PM) in Canada. METHODS: With enrollment still ongoing, 85 patients with Myopic CNV were recruited by ophthalmologists and retina specialists from 16 centres across Canada to participate in this retrospective, multicenter study. Medical records covering at least one year of follow up data from the CNV diagnosis, and up to two years, were analyzed to gather all information related to Myopic CNV. RESULTS:  Data from 67 study participants was analyzed.  Patients had a mean age of 55.4 years (range: 27 – 80 years) at the time of their PM diagnosis (CNV affected eye), and 56.0 years (range: 29 - 82 years) at the time of their first lifetime CNV episode. The analysis showed that 71.6% of participants were female, 71.6% were Caucasian, 61.2% had subfoveal CNV in the affected eye and 31.3% had more than one lifetime CNV episode reported. Based on their visual acuity at the time of CNV diagnosis at the beginning of the chart review period, they were grouped by the Snellen score of the affected eye into 7 groups: 20/32-20/20 (n=5), 20/50-20/32 (n=5), 20/80-20/50 (n=15), 20/125-20/80 (n=12), 20/200-20/125 (n=2), 20/320-20/200 (n=7) and